Praxis Precision Medicines Inc 뉴스 - PRAX | 주식 나스닥

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting

BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage...

Form S-3 - Registration statement under Securities Act of 1933

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Monksdream 2 월 전

PRAX near a 52/week high

Do you still have your 10K shares?

Hope this one goes up to new heights in $5+ in the next month or so.

👍️0

makinezmoney 1 년 전

$PRAX: Added 10k here now at 1.22

Technically........ bullish ...... should get to $1.80 min

GO $PRAX

👍️0

ctb 2 년 전

Despite Trial Failure Praxis Still Seeks Advancing Essential Tremor Program Into Phase 3 Study
Vandana Singh
Fri, March 3, 2023 at 8:05 AM PST

https://finance.yahoo.com/news/despite-trial-failure-praxis-still-160535252.html

Not looking good now.

👍️0

IPO$ 2 년 전

Getting killed this am.

👍️0

IPO$ 2 년 전

FDA phase 2 approval due in next week or so.

👍️0

IPO$ 2 년 전

ATM offering on S-3 didn’t hurt 2022 as avg price was $3.90 per share but not sure on 2023.

👍️0

IPO$ 2 년 전

Book value at 12/31/22 is $76M. Not bad. They say they have enough cash entering 2023.

👍️0

IPO$ 2 년 전

$61M cash at 12/31/22 with 49M shares O/S for about $1.30 in cash per share.

👍️0

IPO$ 2 년 전

I wonder how much cash they have now?

👍️0

ElCollector 2 년 전

$PRAX has $5 a share cash and easily going from $2 to $3 for my collection....patiently waiting

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Praxis Precision Medicines Inc (PRAX)

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

PRAX 뉴스

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting

Form S-3 - Registration statement under Securities Act of 1933

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

PRAX Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Praxis Precision Medicines Inc (PRAX) 뉴스

Praxis Precision Medicines Inc (PRAX)

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

PRAX 뉴스

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting

Form S-3 - Registration statement under Securities Act of 1933

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

PRAX Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기